1. Home
  2. MNPR vs INVZ Comparison

MNPR vs INVZ Comparison

Compare MNPR & INVZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNPR
  • INVZ
  • Stock Information
  • Founded
  • MNPR 2014
  • INVZ 2016
  • Country
  • MNPR United States
  • INVZ Israel
  • Employees
  • MNPR N/A
  • INVZ N/A
  • Industry
  • MNPR Biotechnology: Pharmaceutical Preparations
  • INVZ Auto Parts:O.E.M.
  • Sector
  • MNPR Health Care
  • INVZ Consumer Discretionary
  • Exchange
  • MNPR Nasdaq
  • INVZ Nasdaq
  • Market Cap
  • MNPR 209.3M
  • INVZ 186.3M
  • IPO Year
  • MNPR 2019
  • INVZ N/A
  • Fundamental
  • Price
  • MNPR $35.17
  • INVZ $1.58
  • Analyst Decision
  • MNPR Strong Buy
  • INVZ Strong Buy
  • Analyst Count
  • MNPR 6
  • INVZ 5
  • Target Price
  • MNPR $59.60
  • INVZ $3.38
  • AVG Volume (30 Days)
  • MNPR 55.8K
  • INVZ 8.5M
  • Earning Date
  • MNPR 08-08-2025
  • INVZ 08-06-2025
  • Dividend Yield
  • MNPR N/A
  • INVZ N/A
  • EPS Growth
  • MNPR N/A
  • INVZ N/A
  • EPS
  • MNPR N/A
  • INVZ N/A
  • Revenue
  • MNPR N/A
  • INVZ $34,601,000.00
  • Revenue This Year
  • MNPR N/A
  • INVZ $137.25
  • Revenue Next Year
  • MNPR N/A
  • INVZ $128.53
  • P/E Ratio
  • MNPR N/A
  • INVZ N/A
  • Revenue Growth
  • MNPR N/A
  • INVZ 28.52
  • 52 Week Low
  • MNPR $1.72
  • INVZ $0.45
  • 52 Week High
  • MNPR $54.30
  • INVZ $3.14
  • Technical
  • Relative Strength Index (RSI)
  • MNPR 51.51
  • INVZ 77.76
  • Support Level
  • MNPR $31.17
  • INVZ $1.20
  • Resistance Level
  • MNPR $35.01
  • INVZ $1.58
  • Average True Range (ATR)
  • MNPR 2.10
  • INVZ 0.15
  • MACD
  • MNPR 0.11
  • INVZ 0.05
  • Stochastic Oscillator
  • MNPR 46.49
  • INVZ 91.51

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

Share on Social Networks: